Clinical trial Recruiting at 1 site Observational Ages 18 and up

Combining chest X-rays and arterial blood gas results to predict ventilator need in critically ill adults

Official title: Combining Chest X-Ray Findings With Arterial Blood Gas Analysis for Generation of Machine Learning Model Assessing the Need for Mechanical Ventilation in Critically Ill Patients

Run by Zagazig University · NCT07001696 · Data updated 2026-11-12

This project will test whether a computer model that uses chest X-rays and arterial blood gas results can predict which critically ill adults will need mechanical ventilation.

More Critical Illness trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment2160 (estimated)
SponsorZagazig University
Government
Locations1 site (Zagazig, Al Sharqia)
StatusRecruiting
StartedJune 1, 2025
Main results expectedDecember 31, 2025
Study endsJanuary 30, 2026
Registry record updatedJune 3, 2025
Trial IDNCT07001696 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Critically ill adults (age ≥18) at Zagazig University Hospitals who have both a chest X-ray and an arterial blood gas performed at the time of evaluation are the intended participants.

Probably not a fit

Patients with chronic unrelated lung diseases, pregnant females, or those with missing chest X-ray or ABG data are excluded and may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective cross-sectional study at Zagazig University Hospitals will develop a machine learning model that integrates chest X-ray radiographic features with arterial blood gas (ABG) parameters to predict the need for mechanical ventilation in critically ill adults. About 2,160 patients will be enrolled over six months and data collected will include demographics, clinical status, ABG values (pH, PaO2, PaCO2, HCO3) and radiologic findings (infiltrates, effusions, consolidation). The model will be trained on 70% of the dataset and validated on the remaining 30%, and performance will be compared to standard clinical assessments using metrics such as accuracy and RMSE. The protocol has institutional IRB approval and aims to provide an objective decision-support tool to aid ventilator decision-making.

Why it matters

Potential benefit: If successful, the model could help clinicians make faster, more objective decisions about starting mechanical ventilation and potentially improve patient outcomes.

How similar studies have gone: Machine learning has been applied to imaging or ABG data separately in prior work, but combining both modalities to predict ventilator need is relatively novel and not yet widely validated.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Critically ill adult patients aged 18 years or older.

Patients assessed to require mechanical ventilation.

Control group: Age- and sex-matched critically ill patients not requiring mechanical ventilation.

Availability of both chest X-ray and arterial blood gas (ABG) analysis at the time of evaluation.

Exclusion Criteria:

Patients with missing or incomplete data (e.g., absent chest X-ray or ABG results).

Patients with chronic lung diseases unrelated to the current admission (e.g., COPD, pulmonary fibrosis).

Pregnant females.

Where it's running

  • Faculty of medicine, zagazig university
    Zagazig, Al Sharqia, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.